A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Severe Forehead Lines in Chinese Adult Participants

PHASE3CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

September 13, 2024

Study Completion Date

September 13, 2024

Conditions
Forehead Lines
Interventions
DRUG

BOTOX

Intramuscular Injections

DRUG

Placebo

Intramuscular Injections

Trial Locations (12)

100034

Peking University First Hospital /ID# 249912, Xicheng District

100730

Beijing Hospital /ID# 250059, Beijing

200040

Huashan Hospital, Fudan University /ID# 249854, Shanghai

210008

Nanjing Drum Tower Hospital /ID# 250020, Nanjing

210009

Zhongda Hospital Southeast University /ID# 249970, Nanjing

310014

Zhejiang Provincial People's Hospital /ID# 250120, Hangzhou

430022

Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 250022, Wuhan

510310

Guangdong Second Provincial General Hospital /ID# 250742, Guangzhou

510630

The Third Affiliated Hospital, Sun Yat-Sen University /ID# 250148, Guangzhou

518036

Peking university shenzhen hospital /ID# 249913, Shenzhen

610041

West China Hospital, Sichuan University /ID# 250474, Chengdu

710038

Tangdu Hospital of The Fourth Military Medical University, PLA /ID# 249856, Xi’an

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY